Related Experiment Video

Updated: May 31, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis

Minjung Kim1

  • 1Molecular Oncology Department; Comprehensive Melanoma Research Center; H. Lee Moffitt Cancer Center and Research Institute; Tampa, FL USA.

Small Gtpases
|June 21, 2011
PubMed

Insights

Loss of PTEN tumor suppressor cooperates with RAS activation to drive melanoma development and metastasis. This interaction, studied in mouse models, highlights key genetic drivers of melanoma progression and invasion.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Melanoma frequently exhibits activated RAS/RAF/MAPK and PI3K/AKT pathways.
  • Inactivation of CDKN2A (INK4a/ARF) and PTEN tumor suppressors is common in melanoma.
  • Genetically engineered mouse models have elucidated pathogenetic roles and interactions of these mutations.

Purpose of the Study:

  • To catalog frequent genetic alterations in human melanomas.
  • To describe mouse models for melanoma initiation and progression.
  • To investigate genetic interactions of RAS activation and PTEN loss in a CDKN2A (INK4a/ARF) null background.

Main Methods:

  • Cataloging genetic alterations in human melanomas.
  • Utilizing genetically engineered mouse models for melanoma studies.
  • Employing RNA interference (RNAi) for PTEN inactivation in RAS-driven melanomas.

Main Results:

  • Loss of PTEN cooperates with HRAS activation, promoting melanoma development and metastasis.
  • RNAi-mediated PTEN inactivation in RAS-driven melanomas enhanced migration and invasion.
  • PTEN loss led to E-cadherin downregulation and increased AKT2 phosphorylation, linked to invasion.

Conclusions:

  • Activated RAS cooperates with PTEN loss in melanoma genesis and progression.
  • PTEN loss is a critical factor in RAS-driven melanoma metastasis.
  • Understanding these genetic interactions aids in developing targeted melanoma therapies.

More Related Videos

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma08:18

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...